A Randomized Trial of Convalescent Plasma in Covid-19 Severe Pneumonia

Autor: Pablo J. Camino, Fernando M. Ross, Sebastian Antelo, Pablo Rucci, Eulalia Rodriguez, Alejandra Matteaccio, N. Savoy, Waldo H. Belloso, Lucia Perez, Gabriela Vidiella, Maria Valeria Beruto, Leandro Burgos Pratx, Dean Follmann, Nora Fuentes, Gerardo A. Speroni, Ventura A Simonovich, Wanda Cornistein, Gabriel Funtowicz, Karina Rainero, Erica A. Miyazaki, Marcelo Vallone, Mariano Esperatti, Diego Mario Santoro, Diego Giunta, H. Clifford Lane, Diego Sebastian Ojeda, Omar A. Trabadelo, Walter E. Scordo, Marisa Sanchez, Pablo E. Pardo, Paula Scibona, Inés Ferniot, Hernán G. Michelangelo, Carolina Vázquez, Marcelo H. Losso, Julieta Pasquali, Esteban C. Nannini, Mariano Spotti, Andrea V. Gamarnik

Publikováno v: The New England Journal of Medicine
New England Journal of Medicine
CONICET Digital (CONICET)
Consejo Nacional de Investigaciones Científicas y Técnicas
instacron:CONICET

BACKGROUND:Convalescent plasma is frequently administered to patients with Covid-19 and hasbeen reported, largely on the basis of observational data, to improve clinical outcomes.Minimal data are available from adequately powered randomized, controll

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::14268c97335944b912b0ebd47cd0dd3d
http://www.nejm.org/doi/10.1056/NEJMoa2031304